Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 169.23 | 169.23 | 84.62 | 84.62 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 6,659.53 | 6,286.73 | 6,260.8 | 5,945.48 |
Net Worth | 6,828.76 | 6,455.96 | 6,345.42 | 6,030.1 |
Minority Interest | ||||
Debt | 3,344.2 | 4,575.47 | 3,347.51 | 4,404.14 |
Deferred Tax Liability Net | 1,061.19 | 1,014.15 | 990.42 | 998.58 |
Total Liabilities | 11,234.15 | 12,045.58 | 10,683.35 | 11,432.82 |
Fixed Assets | 8,212.15 | 8,669.78 | 6,818.75 | 7,329.35 |
Intangible Assets | ||||
Investments | 463.31 | 361.21 | 367.64 | 313.92 |
Deferred Tax Asset Net | 405.38 | 612.85 | 796.86 | 1,026.91 |
Networking Capital | 2,044.55 | 2,254.13 | 2,630.64 | 2,696.22 |
Inventories | 1,565.59 | 1,602.23 | 1,797.11 | 1,911.74 |
Inventory Days | 97.28 | 108.17 | ||
Sundry Debtors | 1,571.94 | 1,729.44 | 1,541.35 | 1,544.26 |
Debtor Days | 83.44 | 87.38 | ||
Other Current Assets | 454.84 | 361.66 | 558.25 | 567.02 |
Sundry Creditors | -779.3 | -654.8 | -639.56 | -670.61 |
Creditor Days | 34.62 | 37.94 | ||
Other Current Liabilities | -768.52 | -784.4 | -626.51 | -656.19 |
Cash | 108.76 | 147.61 | 69.46 | 66.42 |
Total Assets | 11,234.15 | 12,045.58 | 10,683.35 | 11,432.82 |
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.
The company announced that its India business grew by 10% year on year in the June quarter, with sales rising to ₹1,635 Crore from ₹1,426 Crore in Q1 FY24.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Bajaj Finance, Vedanta, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice